DOI:
10.1055/s-00034917
Kinder- und Jugendmedizin
LinksClose Window
References
Nigrovic PA, Mannion M, Prince FH. et al.
Anakinra as first-line disease-modifying therapy in systemic juvenile idiopathic arthritis: report of forty-six patients from an international multicenter series.
Arthritis and rheumatism 2011;
63: 545-555.
We do not assume any responsibility for the contents of the web pages of other providers.